Olmesartan generally refers to olmesartan ester tablets. Lacidipine and olmesartan ester tablets can be taken together under the supervision of your doctor. Lacidipine and olmesartan ester tablets are two different types of antihypertensive medications. Lacidipine is a calcium channel blocker and olmesartan ester tablets are selective angiotensin II1 type 1 receptor antagonists, both of which are used in the treatment of hypertension. There are no contraindications to the use of these two drugs and they can be used in combination under the supervision of a physician. The most common adverse reactions to lacidipine are headache, skin flushing, edema, and vertigo, and it needs to be contraindicated in patients with severe aortic stenosis. The combination of lacidipine with angiotensin-converting enzyme inhibitors such as olmesartan ester tablets may produce additive antihypertensive effects. Patients taking olmesartan ester tablets may experience diarrhea, fatigue, chest pain, nausea, etc. Symptoms are usually mild and transient, but overdose of the drug may be small Huainan hypotension and tachycardia, which require prompt medical attention and appropriate treatment. Patients with high blood pressure can follow the doctor’s instructions to use the joint use of lacidipine and olmesartan ester tablets for treatment, but not to self-medication, in order to avoid serious effects.